We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APYX icon
9276
Apyx Medical
APYX
$130M
$649K ﹤0.01%
62,904
+42,071
+202% +$417K
RWO icon
9277
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.28B
$649K ﹤0.01%
12,608
-7,184
-36% -$364K
TCRT icon
9278
Alaunos Therapeutics
TCRT
$4.64M
$649K ﹤0.01%
+1,638
New +$765K
ECHO
9279
PUT
DELISTED
Echo Global Logistics, Inc.
ECHO
$649K ﹤0.01%
21,100
+14,500
+220% +$478K
RARE icon
9280
PUT
Ultragenyx Pharmaceutical
RARE
$2.48B
$648K ﹤0.01%
6,800
-6,700
-50% -$698K
UIVM icon
9281
VictoryShares International Value Momentum ETF
UIVM
$347M
$648K ﹤0.01%
13,046
+6,634
+103% +$331K
CMBT
9282
CMB.TECH NV
CMBT
$5.08B
$648K ﹤0.01%
69,528
-111,285
-62% -$1.01M
DRSK icon
9283
Aptus Defined Risk ETF
DRSK
$1.52B
$647K ﹤0.01%
+21,842
New +$645K
INN
9284
Summit Hotel Properties
INN
$646M
$647K ﹤0.01%
69,306
-51,725
-43% -$511K
PAUG icon
9285
Innovator US Equity Power Buffer ETF August
PAUG
$979M
$647K ﹤0.01%
22,050
-45,996
-68% -$1.34M
KDNY
9286
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$647K ﹤0.01%
45,800
-1,200
-3% -$19.2K
GDS icon
9287
GDS Holdings
GDS
$6.67B
$646K ﹤0.01%
+8,225
New +$638K
KW
9288
PUT
DELISTED
Kennedy-Wilson Holdings
KW
$646K ﹤0.01%
32,500
+22,600
+228% +$457K
PDSB icon
9289
CALL
PDS Biotechnology
PDSB
$12.3M
$646K ﹤0.01%
+51,500
New +$402K
VKTX icon
9290
PUT
Viking Therapeutics
VKTX
$3.87B
$646K ﹤0.01%
107,800
+15,300
+17% +$90.8K
AOA icon
9291
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
$645K ﹤0.01%
9,127
-24,744
-73% -$1.72M
FARO
9292
CALL
DELISTED
Faro Technologies
FARO
$645K ﹤0.01%
8,300
+5,100
+159% +$402K
ANGI icon
9293
PUT
Angi Inc
ANGI
$185M
$644K ﹤0.01%
4,760
-4,350
-48% -$632K
BSM icon
9294
Black Stone Minerals
BSM
$3.1B
$644K ﹤0.01%
59,896
-37,193
-38% -$375K
DIG icon
9295
PUT
ProShares Ultra Energy
DIG
$86.4M
$644K ﹤0.01%
35,600
-12,400
-26% -$207K
FTHM icon
9296
Fathom Holdings
FTHM
$24.6M
$644K ﹤0.01%
19,649
+6,595
+51% +$217K
GTN icon
9297
CALL
Gray Television
GTN
$506M
$644K ﹤0.01%
27,500
-300
-1% -$6.51K
LSI
9298
CALL
DELISTED
Life Storage, Inc.
LSI
$644K ﹤0.01%
6,000
-1,150
-16% -$113K
ARCT icon
9299
PUT
Arcturus Therapeutics
ARCT
$232M
$643K ﹤0.01%
19,000
-44,300
-70% -$1.5M
BLKB icon
9300
PUT
Blackbaud
BLKB
$2.04B
$643K ﹤0.01%
8,400
-31,200
-79% -$2.25M

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.